Medicine News and Research

RSS

BioTrends tracks uptake of Yervoy and Zelboraf for advanced melanoma

BioTrends Research Group, one of the world's leading research and advisory firms for specialized biopharmaceutical issues, has released findings from the second wave of its LaunchTrends® Yervoy and Zelboraf report, in which 103 U.S.-based medical oncologists were surveyed about their current and expected treatment patterns in advanced melanoma.

11 May 2012

Mylan introduces Atorvastatin Calcium in France, Belgium, UK, Ireland and the Netherlands

Mylan Inc. today announced that it has launched Atorvastatin Calcium Tablets, 10 mg, 20 mg, 40 mg and 80 mg in France, Belgium, the UK, the Netherlands and Ireland.

11 May 2012

Research roundup: Health providers' growing clout; The surprising bargain in Part D costs

The Growing Power Of Some Providers To Win Steep Payment Increases From Insurers Suggests Policy Remedies May Be Needed -- Concerns have grown that the consolidation of hospitals and physician groups has increased their ability to raise prices, which increases costs for insurers and patients.

11 May 2012

Lot of fat and few carbohydrates could have better effect on blood sugar levels, lipids in diabetics

People with Type 2 diabetes are usually advised to keep a low-fat diet. Now, a study at Linköping University shows that food with a lot of fat and few carbohydrates could have a better effect on blood sugar levels and blood lipids.

11 May 2012

Safer indoor sex work spaces promote health and safety of street-involved women

Safer indoor sex work spaces provide important and potentially life-saving benefits to sex workers including reduced exposure to violence and HIV and improved relationships with police, according to a study published by the Gender and Sexual Health Initiative of the BC Centre for Excellence in HIV/AIDS (BC-CfE) and the University of British Columbia.

11 May 2012

Researchers develop new form of specially bred mouse that mimics ADHD

The number of attention deficit hyperactivity disorder (ADHD) cases in the United States are exploding. According to a 2011 statement by the Centers for Disease Control and Prevention, nearly one in 10 American children is diagnosed with the disorder.

11 May 2012

New combination therapy offers potential lifetime cure for advanced type 1 diabetes

City of Hope researchers developed a combination therapy to treat late-stage type 1 diabetes that appears to offer a potential lifetime cure for the disease without toxic side effects. The laboratory study is published in the May 9 edition of Science Translational Medicine.

11 May 2012

PET imaging for sudden cardiac arrest can identify candidates for ICDs

New research from the University at Buffalo suggests that cardiologists may have a new way to identify patients who are at the highest risk of sudden cardiac arrest, and the most likely to benefit from receiving an implantable cardiac defibrillator (ICD).

11 May 2012

Top-line results from Takeda vedolizumab phase 3 trial on Crohn's disease

Takeda Pharmaceutical Company Limited today announced top-line results from the international, randomized, placebo-controlled, double-blind GEMINI II pivotal phase 3 trial. The trial evaluated vedolizumab in 1,115 patients with moderately to severely active Crohn's disease who have failed at least one conventional therapy, including TNFα antagonists.

11 May 2012

Citywide ban on public smoking can impact maternal and fetal health

A citywide ban on public smoking in Colorado led to significant decreases in maternal smoking and preterm births, providing the first evidence in the U.S. that such interventions can impact maternal and fetal health, according to an article in Journal of Women's Health, a peer-reviewed publication from Mary Ann Liebert, Inc., publishers.

11 May 2012

African-Americans with scleroderma have more antibodies linked to severe complications

A new analysis finds that compared to Caucasians, African-Americans with systemic scleroderma have more antibodies in the blood that are linked to severe complications and an increased likelihood of death. They say this finding, published today in Arthritis & Rheumatism, suggests physicians can use these disease markers to screen and treat scleroderma patients proactively.

11 May 2012

Foreign aid for health services not significantly displaced, analysis says

In an article published in the May 8 edition of PLoS Medicine, Rajaie Batniji, an affiliate of the Center on Democracy, Development, and the Rule of Law at the Freeman Spogli Institute for International Studies (FSI), and Eran Bendavid of FSI's Stanford Health Policy, found that a 2010 Lancet study by researchers at the University of Washington that "concluded that about half the money given to international governments for providing health care services isn't used as intended" is "flawed" and "should not be used to guide decisions about how much money to give and who should get it," according to a Stanford University news story.

11 May 2012

CAPE arrests growth of prostate cancer tumors

Could it be that a remedy from thousands of years ago holds the secret to stopping prostate cancer? A newly published study furthers the exploration of caffeic acid phenethyl ester (CAPE) and its potential anticarcinogen and antioxidant properties. The demonstrated ability of CAPE to stop prostate cancer tumors from growing may soon have it earning a spot among other natural remedies for prostate cancer treatment.

11 May 2012

Final results from Alnylam’s ALN-TTR01 Phase I trial on TTR-mediated amyloidosis

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today final results from its completed Phase I clinical trial with ALN-TTR01, an RNAi therapeutic targeting transthyretin (TTR) for the treatment of TTR-mediated amyloidosis.

11 May 2012

House passes cuts to health care, other programs to protect Pentagon funding

The Republican-led House has agreed to replace deep budget cuts scheduled to hit the Pentagon in January with a series of reductions in funding for food stamps, Medicaid and regulation of the financial sector. The House approved the package that would save $242.8 billion over 10 years on a party-line 218 to 199 vote. No Democrats supported the package; sixteen Republicans opposed it.

11 May 2012

Interim results from Seattle Genetics’ ADCETRIS phase II trial on CTCL

Seattle Genetics, Inc. today announced that interim results from an investigator-sponsored phase II clinical trial of ADCETRIS (brentuximab vedotin) in patients with relapsed cutaneous T-cell lymphoma (CTCL) were presented at the Society for Investigative Dermatology annual meeting being held May 9-12, 2012 in Raleigh, NC.

11 May 2012

Viewpoints: Can Medicare taxes really fund student loans?; Daschle on diabetes and kids

In the case of the student loans, the Democrats' bill would require certain Americans -- high-income partners in small businesses that provide professional services, such as engineering or lobbying -- to pay payroll taxes on their share of the firm's profits. That's a long way of saying the bill would eliminate a tax-avoidance strategy that some small firms use to reduce their contributions to Social Security and Medicare.

11 May 2012

Patients with mitral regurgitation live longer after surgery

Patients with mitral regurgitation, a type of valvular heart disease common in the elderly, are living longer after surgery, Yale School of Medicine researchers report in the journal Circulation: Cardiovascular Quality and Outcomes.

11 May 2012

NEJM publishes results from Celgene’s REVLIMID phase III studies on MM

Celgene International Sàrl, a subsidiary of Celgene Corporation, today announced that results from three phase III studies evaluating the use of continuous REVLIMID(lenalidomide) treatment in newly diagnosed multiple myeloma (MM) patients or maintenance treatment with lenalidomide following autologous stem cell transplant were published online in the May 10, 2012 edition of the New England Journal of Medicine.

11 May 2012

ICD therapy significantly reduces mortality in patients with moderate heart failure

St. Jude Medical, Inc., a global medical device company, today announced results of the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial) 10-Year Follow-up Study at Heart Rhythm 2012, the Heart Rhythm Society's 33rd Annual Scientific Sessions in Boston. The study demonstrated implantable cardioverter defibrillator (ICD) therapy significantly reduces mortality for at least 11 years in patients with moderate heart failure (HF).

11 May 2012

Medicine News and Research

BioTrends tracks uptake of Yervoy and Zelboraf for advanced melanoma

Mylan introduces Atorvastatin Calcium in France, Belgium, UK, Ireland and the Netherlands

Research roundup: Health providers' growing clout; The surprising bargain in Part D costs

Lot of fat and few carbohydrates could have better effect on blood sugar levels, lipids in diabetics

Safer indoor sex work spaces promote health and safety of street-involved women

Researchers develop new form of specially bred mouse that mimics ADHD

New combination therapy offers potential lifetime cure for advanced type 1 diabetes

PET imaging for sudden cardiac arrest can identify candidates for ICDs

Top-line results from Takeda vedolizumab phase 3 trial on Crohn's disease

Citywide ban on public smoking can impact maternal and fetal health

African-Americans with scleroderma have more antibodies linked to severe complications

Foreign aid for health services not significantly displaced, analysis says

CAPE arrests growth of prostate cancer tumors

Final results from Alnylam’s ALN-TTR01 Phase I trial on TTR-mediated amyloidosis

House passes cuts to health care, other programs to protect Pentagon funding

Interim results from Seattle Genetics’ ADCETRIS phase II trial on CTCL

Viewpoints: Can Medicare taxes really fund student loans?; Daschle on diabetes and kids

Patients with mitral regurgitation live longer after surgery

NEJM publishes results from Celgene’s REVLIMID phase III studies on MM

ICD therapy significantly reduces mortality in patients with moderate heart failure

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News